Integration engines vs AI-native mapping
Rhapsody is the #1 KLAS enterprise engine: reliable, broad, and enterprise-priced. Mirth Connect is the free open-source standard, powerful but you own all the ops. Health1st keeps what's good about engines without the enterprise price or the DIY burden.
- Days to first interface, not weeks or months of hand-building
- Support and validation included, so there's no Mirth DIY tax
- Transparent, published pricing rather than a quote-only enterprise license
MSH|^~\&|EPIC|HOSP|H1ST|DST|202601..||ADT^A01|
PID|1||MRN12345^^^HOSP^MR||DOE^JOHN^A||
19701225|M|||123 MAIN ST^^AUSTIN^TX
PV1|1|I|ICU^101^A|||...admit...
DG1|1|I10|E11.9^Type 2 diabetes mellitusAgent
{ "resourceType": "Patient",
"identifier": [{ "value": "MRN12345" }],
"name": [{ "family": "Doe",
"given": ["John","A"] }],
"gender": "male",
"birthDate": "1970-12-25" }
{ "resourceType": "Condition",
"code": { "coding": [{
"system": "…/icd-10-cm",
"code": "E11.9" }] } }In short
Rhapsody (ex-Lyniate) is the #1 KLAS integration engine, with deep, reliable breadth across HL7 v2, FHIR, X12, C-CDA and DICOM. It now markets Rhapsody Axon agentic AI. It's excellent, but enterprise-priced (quote-only) and config-heavy. Mirth Connect is the free open-source engine used everywhere; its 2024 licensing change spawned the community Open Integration Engine fork. “Free” is real, but you own hosting, scaling, upgrades and support, and you hand-build every channel. Health1st is AI-native: the Mapping Agent drafts v2↔FHIR interfaces that an engineer approves, reaching production in days, with support, validation and transparent pricing built in.
Health1st vs Rhapsody vs Mirth Connect
Rhapsody publishes no pricing (enterprise, quote-only), so its figures are directional. Mirth's core is genuinely free open source with paid support tiers. Treat all cost signals as benchmarks, not quotes.
| Capability | Health1st | Rhapsody | Mirth Connect |
|---|---|---|---|
| Model | AI-native platform | Enterprise engine | Open-source engine |
| Bidirectional HL7 v2 ↔ FHIR | |||
| AI-native mapping (agent-generated) | ~ (Axon, add-on) | ||
| No-code mapping studio | |||
| Time to first interface | Days | Weeks–months | Months (DIY) |
| Vendor support & validation included | |||
| On-prem / private VPC | |||
| Transparent, published pricing | ~ (free core) | ||
| License cost | Subscription + credits | Enterprise custom | Free core |
| Requires in-house HL7 engineers | Optional | Often | Yes |
Hand-built engine vs AI-native mapping
Same destination (a validated, production HL7 v2 ↔ FHIR interface), reached two very different ways.
Traditional engine (Rhapsody / Mirth)
- 1
Scope & license
Enterprise procurement, security review and a quote-only license negotiation — typically a multi-week to multi-month cycle.
- 2
Configure the engine
HL7 analysts build routes and transformations channel by channel. Deep and reliable, but config-heavy and consultant-friendly.
- 3
Test & validate
Hand-built mappings are unit-tested against message samples before promotion to production.
- 4
Operate & maintain
Ongoing engine administration, upgrades and change requests, usually with dedicated integration staff.
Health1st — AI-native, human-in-the-loop
- 1
Connect a source
Point Health1st at a real HL7 v2 feed or FHIR endpoint — no license negotiation to start evaluating.
- 2
AI drafts the mapping
The Mapping Agent proposes a full v2↔FHIR mapping (PID→Patient, PV1→Encounter, DG1 ICD-10 E11.9→Condition) from your actual messages.
- 3
Engineer reviews & approves
A human validates the draft against US Core and FHIR R4.0.1 in a no-code studio. AI drafts; humans ship.
- 4
Go live in days
Approved interface runs in your VPC or on-prem, with support and validation included from day one.
What changes for your team
Speed-to-interface
AI-generated mappings collapse a project measured in weeks or months of channel-building into days of review and approval.
No DIY tax (vs Mirth)
Support, validation, hosting guidance and upgrades are part of the product, so you don't silently pay for them in engineering hours on top of "free."
No enterprise price (vs Rhapsody)
Transparent subscription plus usage credits, published in tiers — instead of a quote-only enterprise license negotiation.
AI-native, not AI-bolted-on
Mapping generation is the core workflow, not an add-on module grafted onto a legacy engine. Rhapsody Axon validates the direction; architecture and economics still differ.
Fewer specialists required
One engineer reviewing AI drafts can replace a squad of HL7 analysts hand-building channels. Expertise helps on edge cases; it's no longer a prerequisite.
CMS-0057-F ready
Patient Access, Provider Access, Payer-to-Payer and Prior Auth (PARDD) FHIR APIs on the mandated stack — ahead of the Jan 1 2027 deadline.
When Rhapsody or Mirth is the better choice
- Rhapsody — a large enterprise needing a battle-tested engine across HL7/FHIR/X12/C-CDA/DICOM at massive scale, with existing HL7 staff and a long procurement runway. 99%+ retention and #1 KLAS ranking are earned.
- Mirth Connect / Open Integration Engine — you have strong in-house integration engineers, low-to-moderate volume, a hard preference for zero license cost, and the operational burden is acceptable.
Both are respected products with huge install bases. Health1st fits best when speed-to-interface, transparent pricing and reduced DIY overhead outweigh those strengths — and we're happy to coexist with an existing engine during migration. See our pricing →
Security & Compliance
Where our compliance actually stands
Protecting PHI is non-negotiable. Here's exactly where our certifications stand — no overclaiming.
Compliant · BAAs available
Audit in progress
On roadmap
Native, by design
AWS HIPAA-eligible infrastructure · Business Associate Agreements (BAAs) · Encryption in transit & at rest · See our security details →
Health1st vs Rhapsody & Mirth — FAQ
Watch AI draft an interface in minutes
Bring an HL7 message type you'd otherwise hand-build in an engine. We'll show the Mapping Agent draft it and an engineer validate it — live.